Behçet's syndrome is not associated with vitiligo

Clinical and Experimental Rheumatology

Volumn 26, Issue 4 SUPPL. 50, 2008, Pages

  Oran, Mustafa ^a   Hatemi, Gulen ^a,c   Tasli, Levent ^b   Garip, Funda ^b   Kadioglu, Pinar ^a   Mat, Cem ^b   Yazici, Hasan ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Autoimmunity; Beh et's syndrome; Graves' disease; Hashimoto's thyroiditis; Vitiligo

Indexed keywords

ADULT; ARTICLE; AUTOIMMUNITY; BEHCET DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GRAVES DISEASE; HASHIMOTO DISEASE; HOSPITAL DEPARTMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SKIN EXAMINATION; UNIVERSITY HOSPITAL; VITILIGO;

ADULT; BEHCET SYNDROME; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMANS; MALE; MIDDLE AGED; VITILIGO;

EID: 55049142139     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. YAZICI H: The place of Behçet's syndrome among the autoimmune diseases. Int Rev Immunol 1997; 14: 1-10.
2. SEHGAL VN, SRIVASTATA G: Vitiligo: Autoimmunity and immune responses. Int J Dermatol 2006; 45: 583-90.
3. HEGEDUS L, HEIDENHEIM M, GERVIL M, HJALGRIM H. HOIER-MADSEN M: High frequency of thyroid dysfunction in patients with vitiligo. Acta Derm Venerol 1994; 74: 120-3.
4. ALKHATEEP A, FAIN PR, THODY A, BENNETT DC, SPRITZ RA: Epidemiology of vitiligo associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res 2003; 16: 208-14.
5. SHONG YK, KIM JA: Vitiligo and autoimmune disease. Thyroidology 1991; 3: 89-91.
6. CRITERIA FOR THE DIAGNOSIS OF BEHÇET'S DISEASE. International Study Group for Behçet's Disease. Lancet 1990; 335: 1078-80.
7. CUNLIFFE WJ, HALL R, NEWELL DJ, STEVENSON CJ: Vitiligo, thyroid disease and autoimmunity. Br J Dermatol 1968; 80: 135-9.
8. ALBRECHT J, ATZENI F, BALDINI C et al.: Skin involvement and outcome measures in systemic autommume diseases. Clin Exp Rheumatol 2006; 24 (Suppl. 40): S52-9.
9. ORTONNE JP, BAHADORAN P, FITZPATRICK TB MOSHER DB, HORI Y: Disorders of melanocytes. In: FREEDBERG IM, EISEN A, WOLFF K (Eds.): Fitzpatrick's Dermatology in General Medicine, McGraw Hill 2003; 842.
10. NAUGHTON GK, EISINGER M, BYSTRYN JC: Antibodies to normal human melanocytes in vitiligo. J Exp Med 1983; 158: 246-51.
11. PARK YK, KIM NS, HANN SK, IM S: Identification of autoantibody to melanocytes and characterization of vitiligo antigen in vitiligo patients. J Dermatol Sci 1996; 11: 111-20.
12. YAZICI H, FRESKO I, DURDAKUL S: Behçet's syndrome: disease manifestations, management, and advances in treatment. Nat Clin Pract Rheumatol 2007; 3: 148-55.
13. DIRESKENELI H: Autoimmunity vs. autoinflammation Dn Behcet's disease: do we oversimplify a complex disorder? Rheumatology (Oxford) 2006; 45: 1461-5.
14. GÜL A: Behçet's disease: an update on the pathogenesis. Clin Exp Rheumatol 2001; 19 (5 Suppl. 24): S6-12.
15. RAMIREZ-PEREDO J, CETINAJA, ALARCON-SEGOVIA D: Sjögren's syndrome in Behçet's disease. Lancet 1973; 2: 732.
16. NAMBA K, OGAWA T, INABA G et al.: [Two cases of Behçet's disease with Sjögren's syndrome]. Rev Med Interne 1993; 14 (Suppl. 1): 55.
17. OTSUKA F, AMANO T, OGURA T, OTA Z: Diabetes insipidus with Behçet's disease. Lancet 1995; 346: 1494-5.
18. CHO SB, CHUN EY, BANG D, LEE KH, LEE ES, LEE S: Coexistence of Behçet's disesase and autoimmune thyroid disease: Clinical features of 11 cases. J Dermatol 2005; 32: 614-6.
19. GUNAYDIN I, USTUNDAG C, KANER G et al.: The prevalence of Sjögren's syndrome in Behçet's syndrome. J Rheumatol 1994; 21: 1662-4.